S&P Dax Mib.. trading

per me si sale, anche il mib sta' tenendo bene, l' euro ha rotto al rialzo su sterlina per bene gli 0,86 e si dirige verso gli 0,90

8179 & 8141 supp diciamo che 8055 & 7966 non ci starebbe male ...

"Aspetterei il test dei minimi di oggi, oppure tu sei comunque ottimista ????" né ottimista né pessimista,opero seguendo......oggi mi va di fare così...faremo questa sera i conti

July 16 2013 Johnson & Johnson Reports 2013 Second-Quarter Results: Sales of $17.9 Billion increased 8.5% Versus 2012 Second Quarter; Second-Quarter EPS was $1.33 Excluding Special Items, 2013 Second-Quarter EPS of $1.48 Increased 13.8%* NEW BRUNSWICK, N.J., July 16, 2013 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced sales of $17.9 billion for the second quarter of 2013, an increase of 8.5% as compared to the second quarter of 2012. Operational results increased 10.0% and the negative impact of currency was 1.5%. Domestic sales increased 8.0%. International sales increased 9.0%, reflecting operational growth of 11.8% and a negative currency impact of 2.8%. Sales included the impact of the acquisition of Synthes, Inc., net of the divestiture of the DePuy trauma business. Excluding this impact, worldwide operational sales growth was 5.6%. Net earnings and diluted earnings per share for the second quarter of 2013 were $3.8 billion and $1.33, respectively. The second quarter results included the gain on the sale of the equity interest owned in Elan Corporation, plc, as previously disclosed. Second quarter 2013 net earnings included after-tax special items of approximately $0.5 billion, related to litigation expenses, integration and transaction costs associated with the acquisition of Synthes, Inc, and program costs associated with the DePuy ASRTM Hip. Second quarter 2012 net earnings included after-tax special items of approximately $2.2 billion as shown in the accompanying reconciliation of non-GAAP financial measures. Excluding these special items, net earnings for the current quarter were $4.3 billion and diluted earnings per share were $1.48, representing increases of 17.7% and 13.8%, respectively, as compared to the same period in 2012.* "Our strong second-quarter results reflect the progress we've made against our near-term priorities of delivering on our financial commitments, restoring a reliable supply of over-the-counter products to consumers, continuing the successful integration of Synthes and building on the momentum in our pharmaceutical business," said Alex Gorsky, Chairman and Chief Executive Officer. "Our talented colleagues at Johnson & Johnson continue to bring meaningful innovations to patients and consumers around the world and have positioned us well to deliver sustainable growth." The Company increased its earnings guidance for full-year 2013 to $5.40 - $5.47 per share. The Company's guidance excludes the impact of special items. Worldwide Consumer sales of $3.7 billion for the second quarter represented an increase of 1.1% versus the prior year consisting of an operational increase of 1.7% and a negative impact from currency of 0.6%. Domestic sales increased 1.0%. International sales increased 1.1%, which reflected an operational increase of 2.0% and a negative currency impact of 0.9%. Positive contributors to operational results were upper respiratory over-the-counter medicines; TYLENOL® and MOTRIN® analgesics; international sales of LISTERINE® mouthwash; baby care products and women's sanitary protection products. Worldwide Pharmaceutical sales of $7.0 billion for the second quarter represented an increase of 11.7% versus the prior year with operational growth of 12.9% and a negative impact from currency of 1.2%. Domestic sales increased 9.1%. International sales increased 14.1% which reflected an operational increase of 16.5% and a negative currency impact of 2.4%. http://www.finanza.com/Finanza/Dati_Bilancio_Mondo/Nord_America/notizia/Johnson__Johnson_utili_e_ricavi_trimestrali_sopra_le_attes-400342 occhio che se questo e' l' andazzo...................... tanto per tornare al discorso dei p/e

16 Luglio 2013 14:11 Sopra 8200 long,sotto short con sar rigido _____________________________ Aspetterei il test dei minimi di oggi, oppure tu sei comunque ottimista ???? Sull' intraday breve.....

sopra 8200 long,sotto short con sar rigido

avevi dubbi?

GS è appena uscita con risultati fenomenali, specie nella branch Investment bank, utili e revenues molto sopra stime...... con i soldi nostri... direbbe qualcuno.....

e se il trend non inverte sul serio non prima di aver tirato a bordo la plebe e non solo. pensieri. ----------------------------------------------------------------------------- infatti, hai centrato in pieno la situazione, nel senso che questa salita e' stata fatta con pochi volumi proprio perche' la plebe non vi e' ancora entrata, cioe' questo movimento che a mio avviso e' solo il pre inizio e' stata fatta dai grandi che hanno rastrellato guardando ai prossimi 2-3 anni ed e' per questo che non ci sono grossi scrolloni sulle salite, perche' non c'e' plebe dentro da spennare. il momento in cui ritornera' la fiducia nella plebe e' ancora molto lontano a mio avviso e quando sara' determinera' l' apice !!!! ciao ps: infatti vedo difficile discese sotto 1550 di s&p 500, anzi eventualmente le reputerei ottime occasioni.

Alcoa deve ancora restituire 300 mln di euro, prendiamoli da loro i soldi e i 300 milionidi crediti azzerati ad Antigua dal bruscoloni?

Le statistiche sono fatte per essere smentite... Quanto partirà il BullMarket di Warren saranno 524.

interessante statistica quale eil numero maggiore di giornate positive in sequenza ?

Vendere il patrimonio pubblico per mantenervi le vostre pensioni dorate.Delinquenti disonesti criminali _______________________________ Ahi ahi, Oscarao lo sento inkakkiato di brutto.... e non ha tutti i torti...... Toh, pare che la serie positiva consecutiva dell' SP500 non capitasse da 10 anni 10 !!!!! Abbiamo benny domani e dopo, mi sembra al Congresso..... ma oggi i fuochi artificiali partono con GS e KO.....

"Budelli: all'asta un altro pezzo di Sardegna" Vendere il patrimonio pubblico per mantenervi le vostre pensioni dorate.Delinquenti disonesti criminali

Draghi in azione...... ECB calls for bids in bond buy sterilisation operation, aims to drain 195.5 bln euros in 7-day funds _______________________________ e non venite a raccontarmi che si tratta di operazione "tecnica"......